Search

Search Results
Results 301 - 310 of 325 for Short bowel syndrome
  • Pradaxa
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Pradaxa (dabigatran etexilate) intended for persons living in Australia.
  • Zypine and Zypine ODT
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Zypine and Zypine ODT (olanzapine) intended for persons living in Australia.
  • Celapram
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Celapram intended for persons living in Australia.
  • Rixadone Oral
    Drug - 9 Feb 2023
    Consumer Medicine Information (CMI) about Rixadone Oral (Risperidone Oral solution 1mg/mL) intended for persons living in Australia.
  • Voltaren Rapid
    Drug - 10 Jan 2023
    Consumer Medicine Information (CMI) about Voltaren Rapid (diclofenac potassium) intended for persons living in Australia.
  • Mizart
    Drug - 10 Oct 2022
    Consumer Medicine Information (CMI) about Mizart (Telmisartan) intended for persons living in Australia.
  • Actemra
    Drug - 5 Sep 2022
    Consumer Medicine Information (CMI) about Actemra intended for persons living in Australia.
  • Reaptan
    Drug - 2 Aug 2022
    Consumer Medicine Information (CMI) about Reaptan (Perindopril/amlodipine [pronounced per-in-do-pril/ am-load-i-peen]) intended for persons living in Australia.
  • Micardis
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Micardis (telmisartan) intended for persons living in Australia.
  • Colese
    Drug - 16 Feb 2022
    Consumer Medicine Information (CMI) about Colese intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback